Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 0 |
| Since 2017 (last 10 years) | 0 |
| Since 2007 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| Children | 1 |
| Disabilities | 1 |
| Drug Therapy | 1 |
| Epilepsy | 1 |
| Incidence | 1 |
| Literature Reviews | 1 |
| Mental Retardation | 1 |
| Normalization (Disabilities) | 1 |
| Outcomes of Treatment | 1 |
| Sleep | 1 |
| More ▼ | |
Source
| Journal of Intellectual… | 1 |
Author
| Clarke, D. | 1 |
| Sajith, S. G. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkSajith, S. G.; Clarke, D. – Journal of Intellectual Disability Research, 2007
Background: Melatonin is used to treat sleep disorders in both children and adults with intellectual disability (ID), although it has no product license for such use. The evidence for its efficacy, potential adverse effects and drug interactions are reviewed in the context of prescribing to people with ID. Methods: A literature search was…
Descriptors: Adolescents, Sleep, Outcomes of Treatment, Normalization (Disabilities)
